Spear Bio plans to use the technology to build a protein detection platform and an assay that can measure levels of neutralizing antibodies against SARS-CoV-2.
The technology fills a present gap in diagnostic testing and could contribute to extending the four walls of the health system for COVID-19 and beyond.
Today, the Wyss Institute for Biologically Inspired Engineering at Harvard University and Spear Bio, Inc.announced that the Institute's DNA nanotechnology-driven ultrasensitive SPEAR protein-detection technology has been licensed to the newly formed Boston-based startup.
Wyss Institute at Harvard University, Aug. 23, 2022 (GLOBE NEWSWIRE) (BOSTON) — Today, the Wyss Institute for Biologically Inspired Engineering at Harvard University and Spear Bio, Inc. announced that